Passing the Pepsi test
The jewel in the crown of PepsiCo is celebrating a decade at the pinnacle of one the world’s most iconic companies – a brand...
Is Twitter falling off its perch?
Departure of Adam Bain may have left social media giant rudderless
By Darren Parkin
"MR. Bain will remain at Twitter in the coming weeks to assist...
L’Oreal sells Body Shop
L’Oreal never quite managed to get to grips with what it bought from Dame Anita Roddick in 2006, but was it all worth it?
WHEN...
Jewel of the Nile loses its sparkle
Fears for a forsaken Egypt as Africa’s fourth largest economy mirrors a Greek tragedy, threatening trade and jeopardising foreign investment
By Darren Parkin
NERVOUS investors are...
World’s richest woman dies
Obituary: Liliane Bettencourt: 1922 - 2017
Controversy and questionable politics were never far away to divert attention from some remarkable skill at leading an industry...
Schneider’s Persistence Pays Off As French Group Takes Control Of Aveva
After several attempts, UK-based Aveva finally gives up majority stake in FTSE software company, gifting shareholders a bonus pay day…
By Darren Parkin
FRENCH industrial giant...
The fail of Berlin?
After months of quiet anxiety about trade conditions for the country, the voices of Germany’s business leaders are becoming louder as they believe they...
Structured Deal
Massive conglomerate in China takes an unusual step by revealing the complex details of its ownership, internal make-up, and investments. In an age of...
Merger brings gene therapy aid for infants closer to production
FDA approves ‘breakthrough therapy’ designation for novel treatment
NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...
Sweet gene victory around the corner? Therapeutic advances come rolling in
As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...
